Position history for CITADEL ADVISORS LLC's holdings in CARDIFF ONCOLOGY INC
CITADEL ADVISORS LLC holds 125,566 shares of CRDF (CARDIFF ONCOLOGY INC), worth $203,417 as of 2026-Q1. The position was increased (+6.2% shares).
Current Value
$203,417
Current Shares
125,566
Total Value Change
+$79,550
Total Shares Change
+69,770
Other major holders of CRDF: RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC
Increased |
| 125,566 |
+6.2% |
| $203,417 |
| 0.0% |
| $1.89 |
17 |
| 2025-Q4 | Increased | 118,188 | +428.4% | $332,108 | 0.0% | $2.87 | 26 |
| 2025-Q3 | New | 22,365 | - | $46,072 | 0.0% | $2.08 | 31 |
| 2025-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $3.15 | 0 |
| 2025-Q1 | Increased | 757,840 | +992.7% | $2.4M | 0.0% | $3.29 | 42 |
| 2024-Q4 | Increased | 69,353 | +37.2% | $300,992 | 0.0% | $4.26 | 31 |
| 2024-Q3 | Decreased | 50,546 | -9.4% | $134,958 | 0.0% | $2.77 | 0 |
| 2024-Q2 | New | 55,796 | - | $123,867 | 0.0% | $2.22 | 34 |